Echocardiography‐defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4770
Abstract: Pulmonary hypertension (PH) is a common but rarely recognized comorbidity of multiple myeloma (MM) patients, while its prognostic significance for MM has been rarely reported. read more here.
Keywords: multiple myeloma; myeloma patients; pulmonary hypertension; echocardiography defined ... See more keywords
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122)
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5657
Abstract: Current guidelines recommend using filgrastim or tbo‐filgrastim to mobilize hematopoietic progenitor cells in an autologous setting. However, previous studies have suggested other forms of granulocyte colony‐stimulating factor (G‐CSF) are equally efficacious, possibly with fewer leukaphereses… read more here.
Keywords: myeloma patients; mobilization hematopoietic; multiple myeloma; hematopoietic stem ... See more keywords
Role of BMI and age in predicting pathologic vertebral fractures in newly diagnosed multiple myeloma patients: A retrospective cohort study
Sign Up to like & getrecommendations! Published in 2018 at "Hematological Oncology"
DOI: 10.1002/hon.2486
Abstract: Vertebral fractures affect approximately 30% of myeloma patients and lead to a poor impact on survival and life quality. In general, age and body mass index (BMI) are reported to have an important role in… read more here.
Keywords: newly diagnosed; age; myeloma patients; multiple myeloma ... See more keywords
COVID-19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
Sign Up to like & getrecommendations! Published in 2023 at "Hematological oncology"
DOI: 10.1002/hon.3127
Abstract: Here we report two cases of myeloma patients who became positive for SARS-CoV-2 infection during the acute phase of autologous stem cell transplant. Both patients were promptly treated with monoclonal antibodies and remdesivir, and, despite… read more here.
Keywords: myeloma patients; autologous stem; covid impact; stem cell ... See more keywords
Clinical significance of cancer-related fatigue in multiple myeloma patients
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Hematology"
DOI: 10.1007/s12185-018-2516-1
Abstract: Cancer-related fatigue (CRF) is one of the adverse events in multiple myeloma (MM) patients treated with cytotoxic agents, proteasome inhibitors (PIs), and immunomodulatory drugs (IMiDs) such as bortezomib, lenalidomide, and thalidomide. The aims of our… read more here.
Keywords: myeloma patients; cancer related; multiple myeloma; related fatigue ... See more keywords
Latest treatment strategies aiming for a cure in transplant-eligible multiple myeloma patients: how I cure younger MM patients with lower cost
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Hematology"
DOI: 10.1007/s12185-020-02841-w
Abstract: This article presents a practical overview of the treatment of younger, newly diagnosed multiple myeloma patients, focusing on novel treatment strategies. With the introduction of effective new agents, multiple myeloma is one of the most… read more here.
Keywords: latest treatment; treatment; treatment strategies; myeloma patients ... See more keywords
Cognition in Multiple Myeloma Patients
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.608
Abstract: Background A major area of concern expressed by multiple myeloma patients is cognitive change after treatment. Cognition is a seldom-reported outcome of treatment for cancer survivors. As disease-free survival continues to improve in the multiple… read more here.
Keywords: myeloma; time; treatment; multiple myeloma ... See more keywords
Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients.
Sign Up to like & getrecommendations! Published in 2018 at "Oral oncology"
DOI: 10.1016/j.oraloncology.2018.07.016
Abstract: About half of individuals diagnosed with medication-related osteonecrosis of the jaw (MRONJ) are multiple myeloma (MM) patients, and most are treated using antibiotics for long-term courses. The penicillin group is recommended as the empiric drug… read more here.
Keywords: related osteonecrosis; myeloma patients; multiple myeloma; empiric antibiotic ... See more keywords
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis
Sign Up to like & getrecommendations! Published in 2017 at "Leukemia"
DOI: 10.1038/leu.2016.381
Abstract: In newly diagnosed myeloma patients, upfront autologous transplant (ASCT) prolongs progression-free survival 1 (PFS1) compared with chemotherapy plus lenalidomide (CC+R). Salvage ASCT at first relapse may still effectively rescue patients who did not receive upfront… read more here.
Keywords: newly diagnosed; myeloma; upfront asct; myeloma patients ... See more keywords
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
Sign Up to like & getrecommendations! Published in 2020 at "Blood Cancer Journal"
DOI: 10.1038/s41408-020-0307-4
Abstract: Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents Roberto Mina , Nisha S. Joseph, Francesca Gay , Efstathios Kastritis , Maria Teresa Petrucci, Jonathan L. Kaufman ,… read more here.
Keywords: clinical features; myeloma patients; patients harboring; survival multiple ... See more keywords
Genomic characterization of functional high-risk multiple myeloma patients
Sign Up to like & getrecommendations! Published in 2022 at "Blood Cancer Journal"
DOI: 10.1038/s41408-021-00576-3
Abstract: Multiple myeloma (MM) patients with suboptimal response to induction therapy or early relapse, classified as the functional high-risk (FHR) patients, have been shown to have poor outcomes. We evaluated newly-diagnosed MM patients in the CoMMpass… read more here.
Keywords: risk; myeloma patients; group; multiple myeloma ... See more keywords